Does RISANKIZUMAB-RZAA Cause Wrong technique in product usage process? 336 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 336 reports of Wrong technique in product usage process have been filed in association with RISANKIZUMAB-RZAA. This represents 0.5% of all adverse event reports for RISANKIZUMAB-RZAA.
336
Reports of Wrong technique in product usage process with RISANKIZUMAB-RZAA
0.5%
of all RISANKIZUMAB-RZAA reports
0
Deaths
14
Hospitalizations
How Dangerous Is Wrong technique in product usage process From RISANKIZUMAB-RZAA?
Of the 336 reports, 14 (4.2%) required hospitalization.
Is Wrong technique in product usage process Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 336 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Wrong technique in product usage process?
EVOLOCUMAB (21,664)
ALBUTEROL (17,114)
ADALIMUMAB (11,766)
PEGFILGRASTIM (10,217)
ETANERCEPT (9,835)
ERENUMAB-AOOE (9,359)
SACUBITRIL\VALSARTAN (8,022)
LEUPROLIDE (5,062)
FENTANYL (2,812)
SEMAGLUTIDE (2,538)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Wrong technique in product usage process Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA